RWE 101 – 4 Potential Uses for Improving Drug Development
Real world data (RWD) refers to any data that is generated outside of a clinical trial setting, such as data collected from electronic health records (EHRs), claims data, and data from wearables and mobile devices. Real world evidence (RWE), on the other hand, is the evidence that is derived from the analysis of RWD, and is used to inform decisions about healthcare interventions.
In other words, RWE is the result of the analysis of RWD in order to generate evidence that can be used to support decision-making in healthcare. RWE is increasingly being used to complement traditional clinical trial data, as it allows for a broader understanding of the effectiveness and safety of treatments in real-world settings, beyond the controlled environment of clinical trials.
For example, RWE can be used to assess the effectiveness of a new drug in a real-world population, by analyzing the outcomes of patients who have received the drug outside of a clinical trial. This can provide valuable insights into the drug’s real-world performance, and help inform clinical practice and regulatory decisions.
Overall, the connection between real-world data and real-world evidence is that RWE is the result of the analysis of RWD, and is used to generate evidence that can be used to inform decisions about healthcare interventions.
Share this story...
Real World Evidence (RWE) 101 – Patient Retention
RWE 101 - Patient Retention Long-term Real-World Evidence (RWE) studies face significant challenges when it comes to patient retention, for several reasons:[1] Time Commitment: Participants in RWE studies are [...]
Real World Evidence (RWE) 101 – Patient Recruitment
RWE 101 - Patient Recruitment Real-world evidence (RWE) is health care information derived from real-world data (RWD). It can be generated through various study designs or analyses, including pragmatic [...]
Real World Evidence (RWE) 101 – HARPER
RWE 101 - HARPER Regulatory agencies, health technology assessors, and payers are increasingly interested in studies that make use of real-world data to inform regulatory and other policy or [...]
Real World Evidence (RWE) 101 – STaRT-RWE
RWE 101 - STaRT-RWE START-RWE (Structured Template for Planning and Reporting on the Implementation of Real World Evidence Studies) was developed to address the need for improved transparency and [...]
Real World Evidence (RWE) 101 – Protocol Design and ISPE GPP
RWE 101 - Protocol Design and ISPE GPP The International Society for Pharmacoepidemiology (ISPE) Guidelines for Good Pharmacoepidemiology Practices (GPP) are a set of best practices for the conduct [...]
Real World Evidence (RWE) 101 – Protocol Design and Scientific Best Practices
RWE 101 - Protocol Design and Scientific Best Practices Designing a robust Real-World Evidence (RWE) study is crucial for generating reliable and valid insights that are acceptable to regulators. [...]
